News Releases

ASOP Global Reaffirms Support for Targeted Section 230 Reform Bill

Applauds Reintroduction of Bipartisan “See Something Say Something Online Act” by Senators Manchin & Cornyn

WASHINGTON – FEBRUARY 1, 2021 – The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to the reintroduction of the See Something Say Something Online Act by Senators Joe Manchin (D-WV) and John Cornyn (R-TX):

ASOP Global applauds Senators Manchin and Cornyn for their work on this bipartisan legislation as part of their continued commitment to protecting consumers from the illegal sale of illicit drugs on the internet. This is especially critical as online drug sellers continue to exploit the ongoing opioid epidemic and now the coronavirus pandemic – preying on consumers who turn to the internet for COVID-19 information and treatments only to find criminals peddling dangerous and even deadly fake products.

By requiring internet companies to report suspicious online criminal activity to law enforcement and holding them liable if they fail to do so, this bill offers a much-needed targeted reform to Section 230 of the Communications Decency Act. Updating outdated Section 230 protections will help stop bad actors from dodging accountability for the content shared and spread through their platforms for far too long.

ASOP Global calls on policymakers to support the See Something Say Something Online Act. This is not about politics – it’s about public health and safety. Congress must act swiftly and prioritize the well-being of patients rather than protecting the criminals hiding behind websites and social media that are fueling the opioid epidemic and pandemic-related fraud online.




The Alliance for Safe Online Pharmacies (ASOP Global), a 501(c)(4) nonprofit organization headquartered in Washington, D.C. with activities in U.S., Canada, Europe, Latin America and Asia, is dedicated to protecting consumers around the world, ensuring safe access to medications, and combating illegal online drug sellers.